Menu

Filtros : "Moraes, Natália V. de" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms (2019)

    Yamamoto, Priscila A.; Benzi, Jhohann R. L.; Azeredo, Francine J.; Dach, Fabiola; Ianhez Júnior, Edgar; Zanelli, Cleslei F.; Moraes, Natália V. de

    Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP

    Subjects: FARMACOGENÉTICA, GENÉTICA, POLIMORFISMO, FARMACOCINÉTICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YAMAMOTO, Priscila A. et al. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, v. 124, n. 3, p. 266-272, 2019Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13126. Acesso em: 11 jun. 2024.

    • APA

      Yamamoto, P. A., Benzi, J. R. L., Azeredo, F. J., Dach, F., Ianhez Júnior, E., Zanelli, C. F., & Moraes, N. V. de. (2019). Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, 124( 3), 266-272. doi:10.1111/bcpt.13126

    • NLM

      Yamamoto PA, Benzi JRL, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/bcpt.13126

    • Vancouver

      Yamamoto PA, Benzi JRL, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/bcpt.13126

  • Artigo de periodico

    Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain (2016)

    Moraes, Natália V. de; Lauretti, Gabriela Rocha; Coelho, Eduardo Barbosa; Godoy, Ana Leonor P. C.; Neves, Daniel V.; Lanchote, Vera Lúcia

    Source: Fundamental and Clinical Pharmacology. Unidades: FMRP, FCFRP

    Subjects: ANALGÉSICOS, CITOCROMO P-450, ESTEROIDES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MORAES, Natália V. de et al. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, v. 30, n. 2, p. 153-161, 2016Tradução . . Disponível em: https://doi.org/10.1111/fcp.12168. Acesso em: 11 jun. 2024.

    • APA

      Moraes, N. V. de, Lauretti, G. R., Coelho, E. B., Godoy, A. L. P. C., Neves, D. V., & Lanchote, V. L. (2016). Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, 30( 2), 153-161. doi:10.1111/fcp.12168

    • NLM

      Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/fcp.12168

    • Vancouver

      Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/fcp.12168
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024